{
  "type": "hyp",
  "text": "In a xenograft model metronomic CPT-11 but not 5-FU and L-OHP markedly inhibits HT-29 tumor growth and microvessel density in the absence of toxicity.\n",
  "self": {
    "NER": {
      "answers": [
        "5-FU",
        "HT-29"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What inhibits HT-29 tumor growth and microvessel density in a x",
          "What tumor does metronomic CPT-11 inhibit?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "a xenograft model metronomic",
        "L-OHP",
        "tumor growth",
        "microvessel density",
        "the absence",
        "toxicity"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "In what model does CPT-11 inhibit HT-29 tumor growth?",
          "What inhibits HT-29 tumor growth and microvessel density in a x",
          "What does CPT-11 inhibit in a xenograft model?",
          "What does L-OHP inhibit in a xenograft model?",
          "In what condition does metronomic CPT-11 inhibit HT-29 tumor growth?",
          "What is the main concern with HT-29 tumor growth?"
        ]
      }
    }
  },
  "asked": {
    "What inhibits HT-29 tumor growth and microvessel density in a x": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.5942503213882446,
        "ground_truth": {
          "5-FU": {
            "bertscore": 0.7021404504776001,
            "f1": 0
          },
          "L-OHP": {
            "bertscore": 0.6547812223434448,
            "f1": 0
          }
        }
      }
    },
    "What tumor does metronomic CPT-11 inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "HT-29",
        "answerability": 0.9455865621566772,
        "ground_truth": {
          "HT-29": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "In what model does CPT-11 inhibit HT-29 tumor growth?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "xenograft model",
        "answerability": 0.9802838563919067,
        "ground_truth": {
          "a xenograft model metronomic": {
            "bertscore": 0.8592510223388672,
            "f1": 0.8
          }
        }
      }
    },
    "What does CPT-11 inhibit in a xenograft model?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "HT-29 tumor growth and microvessel density",
        "answerability": 0.9497648477554321,
        "ground_truth": {
          "tumor growth": {
            "bertscore": 0.7901501655578613,
            "f1": 0.5
          }
        }
      }
    },
    "What does HT-29 tumor growth inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.248399555683136,
        "ground_truth": {
          "microvessel density": {
            "bertscore": 0.692704439163208,
            "f1": 0
          }
        }
      }
    },
    "In what condition does metronomic CPT-11 significantly inhibit HT-29 tumor growth and": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "absence of toxicity",
        "answerability": 0.750970721244812,
        "ground_truth": {
          "the absence": {
            "bertscore": 0.7249927520751953,
            "f1": 0.5
          }
        }
      }
    },
    "What is the main factor that inhibits HT-29 tumor growth?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.42145997285842896,
        "ground_truth": {
          "toxicity": {
            "bertscore": 0.7297959923744202,
            "f1": 0
          }
        }
      }
    }
  }
}